FONAR Board of Directors Announces Receipt of Non-Binding "Take Private" Proposal
FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, has received a preliminary, non-binding "take private" proposal from a Proposed Acquisition Group led by Timothy Damadian. The group, which currently owns 5.01% of FONAR's outstanding stock, aims to acquire all remaining shares at a premium of at least 10% above the 90-day average closing price prior to July 1, 2025.
The Board has formed a special committee of independent directors to evaluate the proposal. FONAR emphasizes that this is only a preliminary indication of interest, and there is no guarantee that any transaction will be approved or completed. Shareholders are not required to take any action at this time.
FONAR Corporation (NASDAQ: FONR), l'inventore della risonanza magnetica MR Scanning™, ha ricevuto una proposta preliminare e non vincolante di "privatizzazione" da un Gruppo di Acquisizione proposto guidato da Timothy Damadian. Il gruppo, che attualmente detiene il 5,01% delle azioni in circolazione di FONAR, intende acquisire tutte le azioni rimanenti offrendo un premio di almeno il 10% sopra il prezzo medio di chiusura degli ultimi 90 giorni prima del 1° luglio 2025.
Il Consiglio di Amministrazione ha costituito un comitato speciale di amministratori indipendenti per valutare la proposta. FONAR sottolinea che si tratta solo di un'indicazione preliminare di interesse e non vi è alcuna garanzia che la transazione venga approvata o completata. Gli azionisti non sono tenuti a intraprendere alcuna azione al momento.
FONAR Corporation (NASDAQ: FONR), el inventor del MR Scanning™, ha recibido una propuesta preliminar y no vinculante de "privatización" por parte de un Grupo de Adquisición propuesto liderado por Timothy Damadian. El grupo, que actualmente posee el 5,01% de las acciones en circulación de FONAR, busca adquirir todas las acciones restantes con una prima de al menos un 10% sobre el precio promedio de cierre de 90 días antes del 1 de julio de 2025.
La Junta ha formado un comité especial de directores independientes para evaluar la propuesta. FONAR enfatiza que esta es solo una indicación preliminar de interés y no hay garantía de que alguna transacción sea aprobada o completada. Los accionistas no están obligados a tomar ninguna acción en este momento.
FONAR Corporation (NASDAQ: FONR), MR 스캐닝™의 발명자는 Timothy Damadian가 이끄는 제안된 인수 그룹으로부터 예비적이고 구속력이 없는 "비상장화" 제안을 받았습니다. 현재 이 그룹은 FONAR의 발행 주식의 5.01%를 보유하고 있으며, 2025년 7월 1일 이전 90일 평균 종가보다 최소 10% 이상의 프리미엄을 붙여 나머지 모든 주식을 인수하려고 합니다.
이사회는 제안을 평가하기 위해 독립 이사들로 구성된 특별 위원회를 구성했습니다. FONAR는 이것이 단지 예비적인 관심 표시일 뿐이며, 거래가 승인되거나 완료된다는 보장은 없다고 강조합니다. 주주들은 현재 아무런 조치를 취할 필요가 없습니다.
FONAR Corporation (NASDAQ: FONR), l'inventeur du MR Scanning™, a reçu une proposition préliminaire et non contraignante de « privatisation » de la part d'un groupe d'acquisition proposé dirigé par Timothy Damadian. Le groupe, qui détient actuellement 5,01 % des actions en circulation de FONAR, vise à acquérir toutes les actions restantes avec une prime de au moins 10 % au-dessus du prix moyen de clôture sur 90 jours avant le 1er juillet 2025.
Le conseil d'administration a formé un comité spécial composé d'administrateurs indépendants pour évaluer la proposition. FONAR souligne qu'il ne s'agit que d'une indication préliminaire d'intérêt et qu'il n'y a aucune garantie qu'une transaction soit approuvée ou réalisée. Les actionnaires ne sont pas tenus de prendre des mesures pour le moment.
FONAR Corporation (NASDAQ: FONR), der Erfinder des MR Scanning™, hat einen vorläufigen, unverbindlichen "Privatisierung"-Vorschlag von einer vorgeschlagenen Erwerbsgruppe unter der Leitung von Timothy Damadian erhalten. Die Gruppe, die derzeit 5,01% der ausstehenden FONAR-Aktien besitzt, beabsichtigt, alle verbleibenden Aktien zu einem Aufpreis von mindestens 10% über dem 90-Tage-Durchschnittsschlusskurs vor dem 1. Juli 2025 zu erwerben.
Der Vorstand hat einen speziellen Ausschuss unabhängiger Direktoren zur Bewertung des Vorschlags gebildet. FONAR betont, dass dies nur eine vorläufige Interessensbekundung ist und keine Garantie besteht, dass eine Transaktion genehmigt oder abgeschlossen wird. Aktionäre müssen derzeit keine Maßnahmen ergreifen.
- Potential premium of at least 10% over 90-day average stock price for shareholders
- Formation of independent special committee to evaluate proposal and protect shareholder interests
- Non-binding nature of the proposal creates uncertainty about deal completion
- Relatively small 5.01% ownership stake by the acquiring group may affect deal credibility
- Limited premium offering of only 10% might be considered low for a take-private transaction
Melville, New York--(Newsfile Corp. - July 9, 2025) - FONAR Corporation (NASDAQ: FONR) ("FONAR"), The Inventor of MR Scanning™, today announced that its board of directors (the "Board") received a preliminary, non-binding proposal letter, dated July 7, 2025 from a Proposed Acquisition Group led by Timothy Damadian and consisting of certain members of the management team and Board of Directors of FONAR Corporation and third parties, to acquire all of the outstanding capital stock of FONAR not currently owned by the Proposed Acquisition Group, at a price per share anticipated to be "at a premium of no less than
The Board has established a special committee consisting of independent and disinterested directors of the Board, who will carefully review the proposal to determine the course of action that is in the best interests of the Company and all shareholders. No action is required by FONAR shareholders at this time.
FONAR cautions its shareholders and others considering trading in FONAR's securities that FONAR has only recently received the proposal letter and has not had an opportunity to carefully review and evaluate the proposal or make any decision with respect to FONAR's response to the proposal. The proposal constitutes only an indication of interest by the Proposed Acquisition Group and does not constitute a binding commitment.
There can be no assurance that the Company will pursue this transaction or other strategic outcome, or that a proposed transaction will be approved or consummated. No agreement, arrangement or understanding between FONAR and the Proposed Acquisition Group relating to any proposed transaction will be created unless definitive documentation is executed and delivered by the appropriate parties.
FONAR does not undertake any obligation to provide any updates with respect to this or any other transaction, or to provide any additional disclosures to reflect subsequent events, new information or future circumstances, except as required under applicable law.
#
About FONAR
FONAR, The Inventor of MR Scanning™, located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI Company in the industry. FONAR went public in 1981 (NASDAQ: FONR). FONAR sold the world's first commercial MRI to Ronald J. Ross, MD, Cleveland, Ohio. It was installed in 1980. Dr. Ross and his team began the world's first clinical MRI trials in January 1981. The results were reported in the June 1981 edition of Radiology/Nuclear Medicine Magazine and the April 1982 peer-reviewed article in the Journal Radiology. The technique used for obtaining T1 and T2 values was the FONAR technique (Field fOcusing Nuclear mAgnetic Resonance), not the back projection technique. www.fonar.com/innovations-timeline.html.
FONAR's signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ Imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® Multi-Position™ MRI often detects patient problems that other MRI scanners cannot because they are lie-down, "weightless-only" scanners. The patient-friendly UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately
FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.
FONAR's primary source of income and growth is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA) www.hmca.com.
FONAR's substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring the Upright cerebral hydraulics of the cerebrospinal fluid (CSF) of the central nervous system. FONAR's UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.
#
UPRIGHT®, and STAND-UP® are registered trademarks. The Inventor of MR Scanning™, CSP™, MultiPosition™, UPRIGHT RADIOLOGY™, pMRI™, CFS Videography™, Dynamic™ and The Proof is in the Picture™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the Company that may or may not materialize. Additional information on factors that could potentially affect the Company's financial results may be found in the Company's filings with the Securities and Exchange Commission.
| NEWS | Fonar Corporation |
| For Immediate Release | The Inventor of MR Scanning™ |
| Contact: Daniel Culver | An ISO 13485 Company |
| Director of Communications | Melville, New York 11747 |
| E-mail: investor@fonar.com | Phone: (631) 694-2929 |
| www.fonar.com | Fax: (631) 390-1772 |
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/258308
FAQ
What is the take-private offer price for FONAR (NASDAQ: FONR) stock?
Who is making the take-private offer for FONAR Corporation?
How much of FONAR stock does the Proposed Acquisition Group currently own?
What actions do FONAR shareholders need to take regarding the take-private proposal?
Is the FONAR take-private deal certain to happen?
